PostęPy w diagnostyce i leczeniu nabytych zastawkowych wad serca
PostęPy w diagnostyce i leczeniu nabytych zastawkowych wad serca
PostęPy w diagnostyce i leczeniu nabytych zastawkowych wad serca
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
8. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the<br />
European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery<br />
(EACTS). Eur Heart J 2010 31(20) s. 2501-2555.<br />
9. Rosinni R. et al.: Long-Term Outcomes In Patients Undergoing Coronary Stenting on Dual Oral Antiplatelet<br />
Treatment Requiring Oral Anticoagulant Therapy. Am J Cardiol 2008, 102 s. 1618-1623.<br />
10. Expert consensus document on management of cardiovascular diseases during pregnancy. The Task<br />
Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of<br />
Cardiology. European Heart Journal, 2003, 24, s. 761-781.<br />
11. Horskotte, D.: Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy<br />
in valvuar heart disease. J Thromb Thrombolysis 1998, 5, s. 19-24.<br />
12. Landefeld, CS., Goldman, L.: Major bleeding in out patients treated with warfarin: relation to protrombine<br />
time and important remedial lesions. Am. J. Med. 1989:87, s. 153-159.<br />
13. Palareti, G., Leali, N., Coccheri, S., et al.: Bleeding complications of oral anticoagulant treatment: an<br />
inception-cohort, prospective collaborative study (ISCOAT). Italian study on complications of oral<br />
anticoagulant therapy. Lancet 1996, 348, s. 423-428.<br />
14. Trupie, AGG., Gunstensen J., Hirsh, J., et al.: Randomized comparison of two intensities of oral anticoagulant<br />
therapy after tissue heart valve replacement. Lancet. 1988, 1, s. 1242-1245.<br />
15. Connolly S.J., M.D. Ezekowitz, S. Yusuf i wsp.: Dabigatran versus warfarin in patients with atrial<br />
fibrillation S.J. Connolly, M.D. The New England Journal of Medicine, 2009; 361: 1139-1151.<br />
16. Patel M.R., Mahaffey K.W., Garg J. and the ROCKET AF Steering Committee for the ROCKET AF<br />
Investigators. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation. N Engl J Med 2011,<br />
365, 883-891.<br />
17. Granger C.B., Alexander J.H., McMurray J.J.V., for the ARISTOTLE Committees and Investigators.<br />
Apixaban versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med 2011, 365, 981-992.<br />
199
Change language